People Search
Phones, Emails, Addresses, Background check, Web references
All public info
Like other search engines (Google or Bing) Radaris collects information from public sources.
By Siddhant Khandekar , Krishna Kiran Konduri: Company Background. Aurobindo Pharma is a leading integrated pharmaceutical company with a strong presence in antibiotics ...
By Siddhant Khandekar , Krishna Kiran Konduri: Company Background. We see greater traction coming from the US generic business (constitutes ~27% of sales) on account of ‘at risk ...
According to Siddhant Khandekar, an analyst with Sunidhi Securities & Finance the present market size for H1N1 vaccine in India is about Rs 3000 crore. he said that this estimate ...
Siddhant Khandekar, Research Analyst with Sunidhi Securities, says: “The investment in UTV will only be beneficial for Walt Disney in the long term.
It is confirmed that Siddhant Khandekar CA-INTER and Ashish Thavkar, MBA research analysts and the authors of this report have not received any compensation from the companies ...
By Siddhant Khandekar , Krishna Kiran Konduri: Company Background. Aurobindo Pharma is a leading integrated pharmaceutical company with a strong presence in antibiotics ...
By Siddhant Khandekar , Krishna Kiran Konduri: Company Background. We see greater traction coming from the US generic business (constitutes ~27% of sales) on account of ...
According to Siddhant Khandekar, an analyst with Sunidhi Securities & Finance the present market size for H1N1 vaccine in India is about Rs 3000 crore. he said that this ...
Mumbai Area, India - Chief Manager- Research at ICICI SecuritiesView Siddhant Khandekar's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Siddhant Khandekar ...
Friends: Dayanand Yadav, Girish Jaiswal, Ashish Dangle, Hemant Ambre, Melvin MirandaSiddhant Khandekar is on Facebook. Join Facebook to connect with Siddhant Khandekar and others you may know. Facebook gives people the power to share and ...
[email protected] Phone: +91- 22- 66318633. Brief Financials Rs. Cr FY06A FY07E FY08F FY09F FY10F. Revenues growth EBITDA % 27% 6.9 47.7 41% ...
1 Jul 2010 ... Find the latest headlines, top news stories for siddhant khandekar Read News stories about, siddhant khandekar siddhant khandekar latest ...
File Format: PDF/Adobe Acrobat -
File Format: PDF/Adobe Acrobat -
File Format: PDF/Adobe Acrobat -
17 Jul 2008 ... Interactive Platform for Finance Professionals & Taxpayers.
12 Jan 2011 ... Siddhant Khandekar, analyst with ICICI Securities, expects 24 percent rise for drugmakers' revenue during the quarter. ...
Linkedin
Sunidhi Securities & Finance Limited (Financial Services industry): Senior Research Analyst, (October 2006-July 2010) Sector- Pharmaceutica...